CID-078

N/A

Report date: 2025/06/20 16:56:04
NME

Base Information

Drug NameCID-078
Drug Alias NameCID-078
ClassificationSmall molecules
Mechanisms of ActionCyclin A inhibitorsCyclin B inhibitors
TargetsCyclin ACyclin B
Therapy Area/IndicationsSolid tumoursLung NeoplasmsTriple Negative Breast Neoplasms +[7] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesCircle Pharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesCircle Pharma Inc
Inactive CompaniesN/A
Active IndicationsSolid tumoursLung NeoplasmsTriple Negative Breast Neoplasms +[6] 
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A